Neurophth Therapeutics / 纽福斯生物科技有限公司
Biotechnology Research • 
Hongshan District, Hubei, China • 21-50 Employees
Company overview
| Headquarters | Hongshan District, Hubei, China |
| Phone number | +862765524119 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Gene Therapy, Biopharmaceuticals, 基因治疗, 眼科疾病 |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
Key Contacts at Neurophth Therapeutics / 纽福斯生物科技有限公司
Su Xiao
Co-Founder, Chief Technical Operations Officer, Board Member
Jane Yang
Hr Executive Director
Fei Wang
Medical Director
天啸 夏
Clinical Operation Director
菲 王
Medical Director
Neurophth Therapeutics / 纽福斯生物科技有限公司 Email Formats
Neurophth Therapeutics / 纽福斯生物科技有限公司 uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@neurophth.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@neurophth.com | 100% |
About Neurophth Therapeutics / 纽福斯生物科技有限公司
At Neurophth, we walk from obstacle to obstacle without loss of enthusiasm. 在纽福斯公司，我们是从一个障碍走向另一个障碍而不丧失热情。 We are China’s first gene therapy company for ophthalmic diseases. Our mission is building a brighter future for patients by innovative gene therapies. Headquartered in Wuhan with subsidiaries in Shanghai, Suzhou, and USA, we are striving to discover and develop gene therapies for patients suffering from blindness and other eye diseases globally. We leverage our AAV and CMC platforms to regain vision in patients suffering from Leber’s hereditary optic neuropathy (LHON), autosomal dominant optic atrophy, vascular retinopathy (wAMD, DME, etc), optic neuropathy (glaucoma, etc) and other genetic diseases. Our most advanced investigational candidate, NR082 (rAAV2-ND4), in development for the treatment of LHON associated with ND4 mutation using a single administration through less invasive intravitreal injection, has received orphan disease designations in the U.S. We are always seeking highly motivated and talented individuals with diverse experiences, abilities and interests who are seeking to inspire the world and help patients to restore vision to join us on our journey. To learn more about Neurophth and our open positions, visit www.neurophth.com.
Neurophth Therapeutics / 纽福斯生物科技有限公司 revenue & valuation
| Annual revenue | $8,000,000 |
| Revenue per employee | $206,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $25,600,000 |
| Total funding | $97,100,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Neurophth Therapeutics / 纽福斯生物科技有限公司 has 8 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Neurophth Therapeutics / 纽福斯生物科技有限公司's funding history, including investment rounds, total capital raised, and key backers.
Neurophth Therapeutics / 纽福斯生物科技有限公司 Tech Stack
Discover the technologies and tools that power Neurophth Therapeutics / 纽福斯生物科技有限公司's digital infrastructure, from frameworks to analytics platforms.
JavaScript graphics
JavaScript libraries
Operating systems
Web servers
JavaScript libraries
UI frameworks
New Zealand
United Kingdom
CanadaFrequently asked questions
4.8
40,000 users
